Additionally, the data demonstrated that FDX1 level was closely related to distinct pathological stages of patients with multiple cancer types; in particular, FDX1 expression indicated a significantly better prognostic survival rate in cancers ESCA, KICH, LIHC, and THCA based on the hepia2 tool and R package “survival”. The gene discussed is FDX1; the disease is cancer.